| |
|
|
|
Berntorp E, Shapiro A, Astermark J, Blanchette VS, Collins PW, Dimichele D, Escuriola C, Hay CR, Hoots WK, Leissinger CA, Negrier C, Oldenburg J, Peerlinck K, Reding MT, Hart C. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia. 2006;12:1-7. Thèmes : Coagulation et fibrinolyse ; maj-2007-04
|
|
|
Berntorp E, Astermark J, Bjorkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia. 2003;9:1-4. Thèmes : Plasma et dérivés plasmatiques ; maj-2003-07
|
|
|
|
|
Perkins J, Kaminer L, Kruskall M, Cannon M, Uhl L, Dzik W, Silver H, O'Neill M, Popovsky M, King K, Ness P, Aubuchon J, Shapiro A, Yomtovian R, Petz LD. Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease? Transfusion. 2000;40:752-753. Thèmes : Transfusion autologue ; Transfusion sanguine à l'étranger
|
|